Evidence for Association of Polymorphisms in CYP2J2 and Susceptibility to Essential Hypertension

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Annals of Human Genetics

• Publication date

  2007-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1469-1809.2007.00346.xPMID 17286575
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci

  2023cited by this paper
• CYP2J2*7 single nucleotide polymorphism in a Chinese population.

  2006influential reference
• Mutation of the Follicle-Stimulating Hormone Receptor Gene 5′-Untranslated Region Associated With Female Hypertension

  2006cited by this paper
• The Prevalence of CYP2C8, 2C9, 2J2, and soluble epoxide hydrolase polymorphisms in African Americans with hypertension.

  2005cited by this paper
• Identification and functional characterization of novel CYP2J2 variants: G312R variant causes loss of enzyme catalytic activity

  2005influential reference
• Single nucleotide polymorphisms in the CYP2J2 and CYP2C8 genes and the risk of hypertension

  2005influential reference
• SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci

  2005cited by this paper
• Risk of Coronary Artery Disease Associated With Polymorphism of the Cytochrome P450 Epoxygenase CYP2J2

  2004cited by this paper
• Association of a promoter variant of the haeme oxygenase-1 gene with hypertension in women

  2003cited by this paper
• Effects of estrogen on gender-related autonomic differences in humans.

  2003cited by this paper
• Cloning of CYP2J2 gene and identification of functional polymorphisms.

  2002cited by this paper
• Soluble Epoxide Hydrolase Inhibition Lowers Arterial Blood Pressure in Angiotensin II Hypertension

  2002cited by this paper
• P450-Dependent Arachidonic Acid Metabolism and Angiotensin II–Induced Renal Damage

  2002cited by this paper
• An efficient procedure for genotyping single nucleotide polymorphisms.

  2001cited by this paper
• Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression

  2001cited by this paper
• Autonomic Function in Hypertensive and Normotensive Subjects: The Importance of Gender

  2001cited by this paper
• Evidence for linkage disequilibrium between the dopamine transporter and bipolar disorder.

  2001cited by this paper
• Increased CYP2J expression and epoxyeicosatrienoic acid formation in spontaneously hypertensive rat kidney.

  2000influential reference
• Suggestions for the nomenclature of human alleles: relevance to ecogenetics, pharmacogenetics and molecular epidemiology.

  2000cited by this paper
• Targeted Disruption of Soluble Epoxide Hydrolase Reveals a Role in Blood Pressure Regulation*

  2000cited by this paper
• High-throughput SNP allele-frequency determination in pooled DNA samples by kinetic PCR.

  2000cited by this paper
• Evidence for association and genetic linkage of the angiotensin-converting enzyme locus with hypertension and blood pressure in men but not women in the Framingham Heart Study.

  1998cited by this paper
• Regulation of CYP3A9 gene expression by estrogen and catalytic studies using cytochrome P450 3A9 expressed in Escherichia coli.

  1997cited by this paper
• Monte Carlo tests for associations between disease and alleles at highly polymorphic loci

  1995cited by this paper
• Endogenous biosynthesis of arachidonic acid epoxides in humans: increased formation in pregnancy-induced hypertension.

  1990cited by this paper

• CYP2J2-mediated metabolism of arachidonic acid in heart: A review of its kinetics, inhibition and role in heart rhythm control.

  2024cites this paper
• Association between CYP4A11 and EPHX2 genetic polymorphisms and chronic kidney disease progression in hypertensive patients.

  2023cites this paper
• Characterization of 15 CYP2J2 variants identified in the Chinese Han population on the metabolism of ebastine and terfenadine in vitro

  2023cites this paper
• CYP2C8 and CYP2J2 gene variations increase the risk of hypertensive intracerebral hemorrhage.

  2022cites this paper
• Cardiomyocyte-specific CYP2J2 and its therapeutic implications

  2022influential citation
• Pharmacogenetics of Direct Oral Anticoagulants

  2021cites this paper
• Sex differences in eicosanoid formation and metabolism: A possible mediator of sex discrepancies in cardiovascular diseases.

  2021cites this paper
• Using Pharmacogenetics of Direct Oral Anticoagulants to Predict Changes in Their Pharmacokinetics and the Risk of Adverse Drug Reactions

  2021cites this paper
• Analysis of CYP2J2 mutations in the Chinese Uyghur population.

  2021cites this paper
• Epoxylipids and Soluble Epoxide Hydrolase in Heart Diseases.

  2021cites this paper
• Influence of the CYP2J2 Gene Polymorphisms on Chronic Obstructive Pulmonary Disease Risk in the Chinese Han Population.

  2020cites this paper
• Epoxyeicosatrienoic acids Improve Glucose Homeostasis by Preventing NF-κB-mediated Transcription of SGLT2 in Renal Tubular Epithelial Cells.

  2020cites this paper
• CYP2J2 Molecular Recognition: A New Axis for Therapeutic Design.

  2020cites this paper
• Analysis of CYP2J2 polymorphisms in the Chinese Uyghur population

  2019cites this paper
• CYP2C11 played a significant role in down-regulating rat blood pressure under the challenge of a high-salt diet

  2019cites this paper
• A comprehensive study revealed SNP–SNP interactions and a sex-dependent relationship between polymorphisms of the CYP2J2 gene and hypertension risk

  2018cites this paper
• Cytochrome P450 2J2: Potential Role in Drug Metabolism and Cardiotoxicity

  2018cites this paper
• Polymorphisms in genes involved in vasoactive eicosanoid synthesis affect cardiovascular risk in renal transplant recipients

  2018cites this paper
• Regulation of CYP2J2 and EET Levels in Cardiac Disease and Diabetes

  2018cites this paper
• The genetic basis of antiplatelet and anticoagulant therapy: A pharmacogenetic review of newer antiplatelets (clopidogrel, prasugrel and ticagrelor) and anticoagulants (dabigatran, rivaroxaban, apixaban and edoxaban)

  2017cites this paper
• The contribution of CYP2C gene subfamily involved in epoxygenase pathway of arachidonic acids metabolism to hypertension susceptibility in Russian population

  2017cites this paper
• Effect of Cytochrome P450 Metabolites of Arachidonic Acid in Nephrology.

  2017cites this paper
• CYP2J2 – regulation, function and polymorphism

  2016cites this paper
• A Genetic Response Score for Hydrochlorothiazide Use: Insights From Genomics and Metabolomics Integration.

  2016cites this paper
• Polymorphisms of drug-metabolizing enzyme CYP 2 J 2 in Wa population from Yunnan Province of China

  2016cites this paper
• A phylogenomic analysis of the role and timing of molecular adaptation in the aquatic transition of cetartiodactyl mammals

  2015cites this paper
• Gender-Specific Effect of CYP2C8*3 on the Risk of Essential Hypertension in Bulgarian Patients

  2015cites this paper
• Human leukocyte antigen-E alleles and expression in patients with serous ovarian cancer

  2015cites this paper
• Intakes of omega-3 polyunsaturated fatty acids and blood pressure change over time: Possible interaction with genes involved in 20-HETE and EETs metabolism.

  2015cites this paper
• Cytochrome P450 genetic variants and hypertension risk in South Indian population

  2014cites this paper
• Cytochrome P 450 genetic variants and hypertension risk in South Indian population

  2014cites this paper
• GW25-e3132 Single nucleotide Polymorphism of the CYP2J2 Gene is Associated with Essential Hypertension in Uygur Population in China

  2014cites this paper
• SNP Interactions in the Genetic Architecture of Blood Pressure

  2013cites this paper
• Association of eNOS (E298D) and CYP2J2 (−50 G/T) gene polymorphisms with hypertension among Egyptian cases

  2013cites this paper
• Cytochrome P450 2J2: distribution, function, regulation, genetic polymorphisms and clinical significance

  2013influential citation
• Roles of the epoxygenase CYP2J2 in the endothelium.

  2013cites this paper
• CYP2J2 −50 G/T and ADRB2 G46A Gene Polymorphisms in Saudi Subjects with Hypertension

  2012cites this paper
• Hypertension, cardiovascular risk and polymorphisms in genes controlling the cytochrome P450 pathway of arachidonic acid: A sex-specific relation?

  2012cites this paper
• PharmGKB summary: cytochrome P450, family 2, subfamily J, polypeptide 2: CYP2J2.

  2011cites this paper
• A Hypertension Gene: Are We There Yet?

  2011cites this paper
• Effect of cytochrome P450 polymorphism on arachidonic acid metabolism and their impact on cardiovascular diseases.

  2010cites this paper
• Transcriptome profiling and network analysis of genetically hypertensive mice identifies potential pharmacological targets of hypertension.

  2010cites this paper
• A comprehensive analysis of gene expression profiles in distal parts of the mouse renal tubule

  2010cites this paper
• Increased CYP2J3 Expression Reduces Insulin Resistance in Fructose-Treated Rats and db/db Mice

  2010cites this paper
• The common functional polymorphism -50G>T of the CYP2J2 gene is not associated with ischemic coronary and cerebrovascular events in an urban-based sample of Swedes

  2010cites this paper
• UNIVERSITY OF FLORIDA THESIS OR DISSERTATION FORMATTING TEMPLATE

  2008cites this paper
• Genetic variation in the cytochrome P450 epoxygenase pathway and cardiovascular disease risk.

  2007cites this paper